Alexandra Martínez-Roca MD.
@amartinezrocamd.bsky.social
Hematologist @hospitalclinic.bsky.social At-home management, #bmtsm #leusm and #CARTcell. Opinions of my own. Colombian dreamer🇨🇴
Pinned
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens
Background: Even though venetoclax in combination with azacitidine (VenAza) is considered a low-intensity regimen, its patients present a high incidence of cytopenia and infections during the first co...
www.mdpi.com
🤩Thrilled to share our latest study:
At-Home (AH) care program for Acute Myeloid Leukemia (AML) for patients undergoing induction therapy with Venetoclax + Azacitidine (VenAza) at @hospitalclinic.bsky.social
www.mdpi.com/2072-6694/16...
At-Home (AH) care program for Acute Myeloid Leukemia (AML) for patients undergoing induction therapy with Venetoclax + Azacitidine (VenAza) at @hospitalclinic.bsky.social
www.mdpi.com/2072-6694/16...
Un merecido reconocimiento al @drmiguelperales.bsky.social por su larga trayectoria.
Siempre dispuesto a compartir conocimientos y procurar que los residentes de España puedan visitar @mskcancercenter.bsky.social. Para mi una de las mejores experiencias de mi residencia.
👏Muchas felicidades👏
Siempre dispuesto a compartir conocimientos y procurar que los residentes de España puedan visitar @mskcancercenter.bsky.social. Para mi una de las mejores experiencias de mi residencia.
👏Muchas felicidades👏
October 9, 2025 at 11:30 AM
Un merecido reconocimiento al @drmiguelperales.bsky.social por su larga trayectoria.
Siempre dispuesto a compartir conocimientos y procurar que los residentes de España puedan visitar @mskcancercenter.bsky.social. Para mi una de las mejores experiencias de mi residencia.
👏Muchas felicidades👏
Siempre dispuesto a compartir conocimientos y procurar que los residentes de España puedan visitar @mskcancercenter.bsky.social. Para mi una de las mejores experiencias de mi residencia.
👏Muchas felicidades👏
Join us on sunday morning at #EHA25 for the EHA - EBMT Joint Symposium!
Yes, I know is early, but I’ll be sure to show you where the good coffee is 😜
Yes, I know is early, but I’ll be sure to show you where the good coffee is 😜
June 13, 2025 at 11:07 AM
Join us on sunday morning at #EHA25 for the EHA - EBMT Joint Symposium!
Yes, I know is early, but I’ll be sure to show you where the good coffee is 😜
Yes, I know is early, but I’ll be sure to show you where the good coffee is 😜
Reposted by Alexandra Martínez-Roca MD.
🚀🧬 Forge your future in science at IDIBAPS and the Hospital Clínic of Barcelona! Join our pioneering CAR-T research team and work towards your PhD. We're seeking bright minds eager to advance cancer therapy.
🔗 www.clinicbarcelona.org/uploads/medi...
#CAR-T #MultipleMyeloma #CancerResearch 🧪🔬
🔗 www.clinicbarcelona.org/uploads/medi...
#CAR-T #MultipleMyeloma #CancerResearch 🧪🔬
www.clinicbarcelona.org
March 14, 2025 at 6:51 PM
🚀🧬 Forge your future in science at IDIBAPS and the Hospital Clínic of Barcelona! Join our pioneering CAR-T research team and work towards your PhD. We're seeking bright minds eager to advance cancer therapy.
🔗 www.clinicbarcelona.org/uploads/medi...
#CAR-T #MultipleMyeloma #CancerResearch 🧪🔬
🔗 www.clinicbarcelona.org/uploads/medi...
#CAR-T #MultipleMyeloma #CancerResearch 🧪🔬
Reposted by Alexandra Martínez-Roca MD.
an important publication highlighting how academic/community communication re recommendations can drive down early mortality in APL and preserve excellent longterm survival!
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
March 2, 2025 at 5:51 PM
an important publication highlighting how academic/community communication re recommendations can drive down early mortality in APL and preserve excellent longterm survival!
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
🤩Thrilled to share our latest study:
At-Home (AH) care program for Acute Myeloid Leukemia (AML) for patients undergoing induction therapy with Venetoclax + Azacitidine (VenAza) at @hospitalclinic.bsky.social
www.mdpi.com/2072-6694/16...
At-Home (AH) care program for Acute Myeloid Leukemia (AML) for patients undergoing induction therapy with Venetoclax + Azacitidine (VenAza) at @hospitalclinic.bsky.social
www.mdpi.com/2072-6694/16...
At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens
Background: Even though venetoclax in combination with azacitidine (VenAza) is considered a low-intensity regimen, its patients present a high incidence of cytopenia and infections during the first co...
www.mdpi.com
December 24, 2024 at 3:39 PM
🤩Thrilled to share our latest study:
At-Home (AH) care program for Acute Myeloid Leukemia (AML) for patients undergoing induction therapy with Venetoclax + Azacitidine (VenAza) at @hospitalclinic.bsky.social
www.mdpi.com/2072-6694/16...
At-Home (AH) care program for Acute Myeloid Leukemia (AML) for patients undergoing induction therapy with Venetoclax + Azacitidine (VenAza) at @hospitalclinic.bsky.social
www.mdpi.com/2072-6694/16...